Mcmorgan & CO LLC Catalent, Inc. Transaction History

Mcmorgan & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $65,790 - $138,891	2,065 Added 5.31%	40,940 $1.78 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $31,353 - $51,239	-690 Reduced 1.74%	38,875 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $1.22 Million - $2.39 Million	29,484 Added 292.47%	39,565 $1.78 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $1,447 - $2,262	-20 Reduced 0.2%	10,081 $729,000
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $163,936 - $214,414	1,880 Added 22.87%	10,101 $1.08 Million
Q1 2022 May 17, 2022	SELL	$94.19 - $124.49 $80,532 - $106,438	-855 Reduced 9.42%	8,221 $911,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $253,488 - $294,828	2,120 Added 30.48%	9,076 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $759,386 - $990,186	6,956 New	6,956 $925,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Mcmorgan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Mcmorgan & CO LLC with notifications on news.